Queen's Hospital is a hospital in Romford in the London Borough of Havering. It was built on the site of the former Oldchurch Park, a short distance south of the town centre. It is run by Barking, Havering and Redbridge University Hospitals NHS Trust.

There are 939 beds in Queen's Hospital.

During the past decade, Queen's Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 12 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen's Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "University College, London" with 4 trials sponsored, "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Medical Research Council" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's Hospital" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "American College of Rheumatology" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Queen's Hospital" are "Prostate Cancer" (5 trials), "Colorectal Cancer" (4 trials), "Breast Cancer" (3 trials), "Cardiovascular Disease" (2 trials) and "Diffuse Large B Cell Lymphoma" (2 trials). Many other conditions were trialed in "Queen's Hospital" in a lesser frequency.

Most popular intervention types in "Queen's Hospital" are "Drug" (34 trials), "Procedure" (7 trials), "Other" (6 trials), "Radiation" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Rituximab" (4 trials), "Cyclophosphamide" (3 trials), "Prednisolone" (3 trials) and "quality-of-life assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Queen's Hospital" are 39 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Queen's Hospital". undefined are not yet recruiting, 7 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Queen's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Queen's Hospital, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".